Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
But in 10k says expects to continue to see losses. Speaking out of both sides of his mouth
To say you haven't lost anything unless you sell is idiotic. I know peopke who lost their shirts because tgey didn't sell and were left holding a worthless stock. If one day you have 5 grand and next day you have 3g, you lost 2g. Simple math.
Give it time, I never said it will happen immediately.
I wish you luck with that. I'll get back in when this stock hits .05 EOM.
Everyone was talking about loans. They have 500 mil shares waiting to be dolled out. How about they start selling some product. What happens when they run out of those shares? Authorize some more and doll them out. Then R/S rinse and repeat.
The company told us they are going to dilute this stock even more.
They CLEARLY say that they will be dolling out more shares to THE PUBLIC or directly to Priate investors to raise money. What you point out as to what they did in Feb was to pay debts, not to raise money. Dilution coming BIG time. In my EDUCATED opinon based on my DD.
The Company anticipates having to raise additional capital to fund operations over the next 12 months. To the extent that it is required to raise additional funds to acquire properties, and to cover costs of operations, the Company intends to do so through additional public or private offerings of debt or equity securities
Interesting how the huge Fluffy PR campaign started around the time they dolled out all these shares and then in a short period of time there were huge increases in volume and share price, a unexplained run up to .24 and just as quick crash back down to .18 in less than an hour.
On February 9, 2012, the Company signed a license agreement with Apothecary Genetics Investments LLC. to produce several Cannabis Science Brand Formulations for the California medical cannabis market. As well, Apothecary will provide research and development facilities with full circle operations including a California laboratory facility for internal research and development, along with 16 unique genetic strains specifically generated and maintained by a cancer survivor who recognizes the importance of proper growth and breeding. In consideration of this agreement, on January 1, 2012, the Company entered into a 25 year management agreement with Dr. Mohammad Afaneh to act Chief Operating Officer of Cannabis Science, Inc. Dr. Afaneh received 28,500,000 common shares valued at $299,250 under this agreement. In addition, on February 10, 2012, Dr. Afaneh signed a management bonus agreement where he received 5,000,000 common shares valued at $185,000 as a signing bonus for entering into his management agreement. In addition, on January 1, 2012, the Company entered into a 25 year management agreement with Bret Bogue to act as Director of Horticulture and head of research and development. Mr. Bogue received 28,500,000 common shares valued at $299,250 under this agreement. In addition, on February 10, 2012, Mr. Bogue signed a management bonus agreement where he received 5,000,000 common shares valued at $185,000 as a signing bonus for entering into his management agreement.
On February 9, 2012, the Company acquired GGECO University, Inc. ( “ GGECO ” ), an online video-based medical cannabis education system, offering courses dealing with medical cannabis law, the benefits of medical marijuana, cooking, horticulture, and bud tending. Following the university's name change to Cannabis Science University, the Company hopes to use this platform to educate the general public, patients, and even those who have already been involved in the medical cannabis industry on the medical benefits of cannabis, how it is grown, how to use it safely, and the many applications or ways to administer the medication. In consideration of this agreement, the Company issued 25,000,000 common shares to the principals of GGECO.
4
On March 21, 2012, the Company acquired Cannabis Consulting Inc. ( “ CCI Group ” ), which consists of a group of businesses operated by Robert J. Kane, including: all contracted rights, properties, patents, trademarks, and distribution rights and agreements pertaining to Cannabis Consulting Inc., Robert Kane
Partners, Kaneabis Consulting, Kaneabis Fund, Kaneabis Report, and Kaneabis Radio. In conjunction with the acquisitions, Robert Kane was promoted to V.P. of Investor Relations for the Company. Consideration paid for the CCI Group was 1,000,000 common shares to issued to the principal, Mr. Robert Kane.
They say in the 10K that they do plan to dilute. They say they will be needing to raise funds through more public or private offerings of shares.
More dilution to come. CBIS tells us in the 10K that it will be diluting the stock even further. There is still aprox 1/2 billion A/S not is circulation yet.
The Company anticipates having to raise additional capital to fund operations over the next 12 months. To the extent that it is required to raise additional funds to acquire properties, and to cover costs of operations, the Company intends to do so through additional public or private offerings of debt or equity securities.
No, I am not contradicting myself. The company is giving shares away to debtholders. When you buy shares, you are not buying from the company, but from another indivudual who already owned the shares. The company doesnt get the money. Tbe only way a company makes money off the shares is by directly selling them. That is not what they are doing.
Yes, we invest to make money, but we are not helping the company raise money by buying shares in the open market. Unless you are buying directly from the company, you are not financing the company, just the current owner of the shares.
Point taken, but it seems they are only using it so far to pay off consultants. If they do use it to raise funds to pay off debt and FDA trials, that is a different story. We will see what the 10 k shows. I like the concept of the stock, just concerned about the financial health of it. I am waiting for the 10k to see if I will jump back in.
Chloraphil. Sorry couldn't resist.
Basically, it means that the company is creating more shares from thin air to pay off debt. They are giving shares away to consultants etc because they can't pay them cash. The more shares outstanding, the less % of a company each share represents. So everytime they issue more shares, the shareholders % ownership goes down and so does the value of each share. Law of supply and demand. It is also an indicator that the company is in finacial difficulties.
This is from their website.
800 mil is Authorized shares, up from 250 mil at end of last qtr.
352 mil is Outstanding shares up almost 100% from end of last qtr.
INVESTORS OVERVIEW
Investors
Authorized Preferred Shares
1,000,000
Issued Preferred Shares
1,000,000 Authorized Commom Shares
800,000,000
Issued Common Shares
352,920,574
Could the rumored 4/20 PR be Green Assets dumping big bucks into this company? Buy the rumor sell the news!!
Thank you Pollux
Are you sure they are doing trials overseas? Where did you get that info, I would like to see it. Thanks
Just the opposite IMO
Good move. That is what I was talking about
This is according to their website. This could change one the 10k comes out
INVESTORS OVERVIEW
Investors
Authorized Preferred Shares
1,000,000
Issued Preferred Shares
1,000,000
Authorized Commom Shares
800,000,000
Issued Common Shares
352,920,574
WOW!!! I wish CBIS owed me some money..they would pay me in shares worth 400x what they owed me. Glad to see they dilute shares responsibly.
On July 26, 2011: Cannabis Science issued 1,400,000 common shares, with a fair market value of $0.04 per share, for settlement of $1,400 of shareholder debt assigned from the shareholder note payable originating on December 16, 2010 and owing at December 31, 2010.
July 27, 2011: Cannabis Science issued 6,000,000 common shares, with a fair market value of $0.04 per share, for settlement of $6,000 of shareholder debt assigned from the shareholder note payable originating on July 9, 2010 and July 15, 2010 and owing at December 31, 2010.
July 28, 2011: Cannabis Science issued 3,000,000 common shares, with a fair market value of $0.05 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on July 9, 2010 and owing at December 31, 2010.
August 8, 2011: Cannabis Science issued 3,400,000 common shares, with a fair market value of $0.04 per share, for settlement of $3,400 of shareholder debt assigned from the shareholder note payable originating on December 16, 2010 and owing at December 31, 2010.
August 16, 2011: Cannabis Science issued 3,000,000 common shares, with a fair market value of $0.04 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on August 16, 2010 and owing at December 31, 2010.
September 6, 2011: Cannabis Science issued 3,500,000 common shares, with a fair market value of $0.03 per share, for settlement of $3,500 of shareholder debt assigned from the shareholder note payable originating on July 15, 2010 and owing at December 31, 2010.
September 14, 2011: Cannabis Science issued 3,000,000 common shares, with a fair market value of $0.03 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on July 30, 2010 and owing at December 31, 2010.
September 22, 2011: Cannabis Science issued 3,500,000 common shares with a fair market value of $105,000 to a consultant for services rendered to the Company; pursuant to a consulting agreement entered into on August 10, 2011 with services to be provided through August 31, 2013.
That’s a total of 26,800,000 shares issued (valued at aprox $1.72 mil when issued) in the quarter to pay off $106,000 in debts.
I just saw CBIS scrol accross the CNBC ticker
How do you know more news coming? Inside info?
maybe there is .6 billion A/S. Are we at .6 yet?
Who cold that be? YOU? Or do you have insider info or work for the company?
We already know from their last qtr. 10q they raised the authorized shares from 250 mil to 850 mil. I bet the 10 k shows over 1 billion in A/S and 400 mil O/S.
Doesn't say it is ready, says they are going to start to prepare the package. Doesn't say anything is ready to be submitted. You have selective reading skills.
The Company has received from our consultants its initial review for Pre-IND preparation work and for the submitting Pre-IND request letter. With several questions answered and confirmed for the Company, the Company will sign off and its’ consultants will prepare the Pre-IND meeting submission package.
Doesn't mean they will. Just because states lagalize it, it doesn't mean the feds will change anything. It doesn't force them to do squat.
Maybe you should do some research and see what post I was commenting on.
You need to read better. NO WHERE does it say the application is ready for submital.
How will that get it to schedule 2. FDA scheduling is based on federal law and has NOTHING to do with what the states do. Federal law trups state law.
Don't get me wrong, his credential are impressive. Just responding when someone said he was an MD.
Hammer, the CEO is not a medical doctor.
Paid pumps and the stock is flat. What does that tell you?
Gomez, thanks for the tip on that G*G* pick. Moving up nicely.
Because the shares are so dillutied by now that it takes a mountain to keep the pps stable.
Ok, so now they are paying for promo's. Just like a typical PnD. Dump coming right before 10k released. IMHO